Larimar Therapeutics, Inc.

Q2 2020 13F Holders

Symbol
LRMR
CUSIP
517125100
Type
Equity
Class
COM
Num filings
38
Total reported value, excl. options
$166 M
Manager Report Date Value ($000) Shares Option Type